Skip to main content

Table 5 Evolution of symptoms between the previous (2014) and current (2015) pollen seasons

From: An observational cohort study of the use of five-grass-pollen extract sublingual immunotherapy during the 2015 pollen season in France

 

Children (N = 203)

Adults (N = 283)

2014 pollen season

2015 pollen season

2014 pollen season

2015 pollen season

Reported symptoms, n (%)

 Unilateral nose symptoms

27 (13.3%)

23 (11.3%)

35 (12.5%)

53 (18.9%)

 Viscous purulent rhinorrhoea

12 (5.9%)

1 (0.5%)

7 (2.5%)

13 (4.6%)

 Abundant rhinorrhoea/posterior draining

94 (46.3%)

38 (18.7%)

154 (55.0%)

66 (23.6%)

 Facial pain

15 (7.4%)

5 (2.5%)

51 (18.2%)

18 (6.4%)

 Recurrent nose bleeds

28 (13.8%)

17 (8.4%)

15 (5.4%)

12 (4.3%)

 Hypo-osmia

57 (28.1%)

18 (8.9%)

94 (33.6%)

44 (15.7%)

Reported symptoms most days, n (%)

 Watery rhinorrhoea

191 (94.1%)

102 (50.2%)

276 (98.6%)

130 (46.4%)

 Repetitive sneezing

192 (94.6%)

91 (44.8%)

275 (98.2%)

145 (51.8%)

 Blocked nose

171 (84.2%)

84 (41.4%)

243 (86.8%)

93 (33.2%)

 Nasal pruritus

154 (75.9%)

76 (37.4%)

243 (86.8%)

115 (41.1%)

 Signs of conjunctivitis

171 (84.2%)

86 (42.4%)

252 (90.0%)

118 (42.1%)

Symptom frequency, n (%)

 Less than 4 days per week

19 (9.4%)

151 (74.4%)

23 (8.2%)

183 (65.4%)

 More than 4 days per week

184 (90.6%)

50 (24.6%)

257 (91.8%)

90 (32.1%)

Symptom duration, n (%)

 Less than 4 weeks

17 (8.4%)

156 (76.8%)

16 (5.7%)

175 (62.5%)

 More than 4 weeks

186 (91.6%)

46 (22.7%)

264 (94.3%)

100 (35.7%)

Symptom impact: sleep, n (%)

 Normal

104 (51.2%)

174 (85.7%)

120 (42.9%)

227 (81.1%)

 Disturbed

99 (48.8%)

29 (14.3%)

160 (57.1%)

53 (18.9%)

Symptom impact: social and recreational activities, n (%)

 Normal

83 (40.9%)

174 (85.7%)

95 (33.9%)

234 (83.6%)

 Disturbed

120 (59.1%)

27 (13.3%)

185 (66.1%)

46 (16.4%)

Symptom impact: professional and/or school activities, n (%)

 Normal

95 (46.8%)

29 (14.3%)

116 (41.4%)

232 (82.9%)

 Disturbed

108 (53.2%)

172 (84.7%)

163 (58.2%)

47 (16.8%)

Symptom impact: uncomfortable symptoms, n (%)

 Not particularly uncomfortable

20 (9.9%)

155 (76.4%)

11 (3.9%)

199 (71.1%)

 Uncomfortable

183 (90.1%)

48 (23.6%)

269 (96.1%)

81 (28.9%)

Symptom frequency, n (%)

 Intermittent

30 (14.8%)

174 (85.7%)

34 (12.1%)

210 (75.0%)

 Persistent

173 (85.2%)

27 (13.3%)

246 (87.9%)

64 (22.9%)

Allergy severity, n (%)

 Mild

15 (7.4%)

134 (66.0%)

4 (1.4%)

173 (61.8%)

 Moderate or severe

188 (92.6%)

69 (34.0%)

276 (98.6%)

107 (38.2%)